\(
\def\WIPO{World Intellectual Property Organisation}
\)
Effective drug regulation : a multicountry study / by Sauwakon Ratanawijitrasin, Eshetu Wondemagegnehu.
Ratanawijitrasin, Sauwakon, author.; ebrary, Inc.; Ratanawijitrasin, Sauwakon.; Wondemagegnehu, Eshetu, Contributor.; World Health Organization. Essential Drugs And Medicines Policy.; World Health Organization Essential Drugs And Medicines Policy.; Weltgesundheitsorganisation. Essential Drugs And Medicines Policy Division.; World Health Organization.; Organización Mundial De La Salud.
2002
G 25 RAT.E
Available at WIPO Library
Items
Details
Title
Effective drug regulation : a multicountry study / by Sauwakon Ratanawijitrasin, Eshetu Wondemagegnehu.
Author
Description
ix, 47 pages ; [28] cm.
ISBN
9241562064
0585473161 electronic book
9780585473161 electronic book
9240680292
9789240680296
9789241562065
1280060387
9781280060380
9786610060382
661006038X
0585473161 electronic book
9780585473161 electronic book
9240680292
9789240680296
9789241562065
1280060387
9781280060380
9786610060382
661006038X
Alternate Call Number
G 25 RAT.E
Summary
Drugs play a crucial role in saving lives, restoring health, and preventing diseases and epidemics. But they need to be safe, efficacious, of good quality, and used rationally. This means that their production, import/export, storage, supply and distribution should be subject to government control through prescribed norms and standards and an effective regulatory system. Substandard and counterfeit drugs proliferate primarily in an environment where drug regulation has proved ineffective. This publication presents a synthesis of studies on drug regulation carried out in 10 countries: Australia.
Note
"This report is a synthesis of the results of the multicountry studies carried out by the WHO Essential Drugs and Medicines Policy Unit (EDM)"--Page ix.
Formatted Contents Note
1. DRUG REGULATION: OBJECTIVES AND ISSUES; 2. MULTICOUNTRY STUDY ON EFFECTIVE DRUG REGULATION; 3. PROFILE OF THE COUNTRIES; 4. REGULATORY FRAMEWORK; 5. REGULATORY CAPACITY; 6. LICENSING OF MANUFACTURING, DISTRIBUTION AND RETAIL SALE; 7. INSPECTION AND SURVEILLANCE; 8. PRODUCT ASSESSMENT AND REGISTRATION; 9. CONTROL OF DRUG PROMOTION AND ADVERTISING; 10. DRUG QUALITY CONTROL LABORATORY; 11. ASSESSING REGULATORY PERFORMANCE; 12. CONCLUSIONS AND RECOMMENDATIONS FOR EFFECTIVE DRUG REGULATION.
Series
Series
Academic Search Complete.
Published
[Geneva] : World Health Organization, 2002.
Language
English
Record Appears in